Annual Drug Patent Expirations for REZLIDHIA
Rezlidhia is a drug marketed by Rigel Pharms Inc and is included in one NDA. It is available from one supplier. There are ten patents protecting this drug.
This drug has seventy-four patent family members in thirty-six countries.
The generic ingredient in REZLIDHIA is olutasidenib. One supplier is listed for this compound. Additional details are available on the olutasidenib profile page.
For more information on how DrugPatentWatch can help with your pharmaceutical business intelligence needs, contact admin@DrugPatentWatch.com or visit www.DrugPatentWatch.com
